D F Zullino, C B Eap, P Voirol. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/pharmacokineticsAntipsychotic Agents/therapeutic useBenzodiazepinesClozapine/adverse effectsClozapine/pharmacokineticsClozapine/therapeutic useDrug InteractionsDyskinesia, Drug-Induced/drug therapyDyskinesia, Drug-Induced/etiologyHumansOlanzapineOndansetron/pharmacokineticsOndansetron/therapeutic usePirenzepine/adverse effectsPirenzepine/analogs & derivativesPirenzepine/pharmacokineticsPirenzepine/therapeutic useReceptors, Serotonin/drug effectsSerotonin Antagonists/pharmacokineticsSerotonin Antagonists/therapeutic use
Substances： See more » Antipsychotic AgentsReceptors, SerotoninSerotonin AntagonistsBenzodiazepinesPirenzepineOndansetronClozapineOlanzapine
Year: 2001 PMID： 11282718 DOI： 10.1176/appi.ajp.158.4.657-a
Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112